SCHEDULE 13D/A 0001493152-24-049867 0001261725 XXXXXXXX LIVE 20 Common Stock, par value $0.02 per share 02/06/2025 false 0000771999 26253C201 DSS, INC.

275 Wiregrass Pkwy West Henrietta NY 14586

Heng Fai Ambrose Chan 011 65 6333 9181 9 Temasek Boulevard #16-04, Suntec Tower Singapore U0 038987 0001261725 N Heng Fai Ambrose Chan PF N U0 6148664.00 0.00 6148664.00 0.00 6148664.00 N 67.6 IN (1) The beneficial ownership of Heng Fai Ambrose Chan includes 6,148,664 shares of common stock, consisting of (a) 1,002,978 shares of common stock held by Heng Fai Holdings Limited, an entity controlled by Heng Fai Ambrose Chan; (b) 1,184,475 shares of common stock held by Heng Fai Ambrose Chan directly; (c) 311,634 shares of common stock held by Global Biomedical Pte. Ltd., a subsidiary of Alset International Limited; (d) 2,581,268 shares of common stock held by Alset Inc.; and (e) 1,068,309 shares of common stock held by Alset International Limited, a subsidiary of Alset Inc. (2) Based on 9,092,518 shares of the common stock of the Issuer outstanding as of February 6, 2025. 0001750106 N Alset Inc. OO N TX 3961211.00 0.00 3961211.00 0.00 3961211.00 N 43.6 CO (1) Includes 2,581,268 shares of common stock held directly by Alset Inc.; 311,634 shares of common stock held by Global Biomedical Pte. Ltd., a subsidiary of Alset International Limited; and 1,068,309 shares of common stock held by Alset International Limited, a subsidiary of Alset Inc. (2) Based on 9,092,518 shares of the common stock of the Issuer outstanding as of February 6, 2025. Y Global Biomedical Pte. Ltd. OO N U0 311634.00 0.00 311634.00 0.00 311634.00 N 3.4 CO Based on 9,092,518 shares of the common stock of the Issuer outstanding as of February 6, 2025. 0001660984 N Alset International Limited OO N U0 1379943.00 0.00 1379943.00 0.00 1379943.00 N 15.2 CO Based on 9,092,518 shares of the common stock of the Issuer outstanding as of February 6, 2025. Common Stock, par value $0.02 per share DSS, INC. 275 Wiregrass Pkwy West Henrietta NY 14586 Heng Fai Ambrose Chan c/o Alset International Limited, 9 Temasek Boulevard #16-04, Suntec Tower Two, Singapore 038987 Chairman and Chief Executive Officer, Alset International Limited, 9 Temasek Boulevard #16-04, Suntec Tower Two, Singapore 038987 Singapore On February 6, 2025, the Issuer awarded Mr. Chan (through his personally owned company, Heng Fai Holdings Limited) a stock grant of 1,000,000 newly issued shares of the Issuer's common stock pursuant to the Issuer's 2020 Employee, Director and Consultant Equity Incentive Plan. On February 6, 2025, the Issuer awarded Mr. Chan (through his personally owned company, Heng Fai Holdings Limited) a stock grant of 1,000,000 newly issued shares of the Issuer's common stock pursuant to the Issuer's 2020 Employee, Director and Consultant Equity Incentive Plan. Heng Fai Ambrose Chan: 6,164,664, 67.6% Alset Inc.: 3,961,211, 43.6% Global Biomedical Pte. Ltd.: 311,634, 3.4% Alset International Limited: 1,379,943, 15.2% Heng Fai Ambrose Chan: 6,164,664 Alset Inc.: 3,961,211 Global Biomedical Pte. Ltd.: 311,634 Alset International Limited: 1,379,943 On December 10, 2024, Alset Inc. entered into a stock purchase agreement with the Issuer, pursuant to which Alset Inc. agreed to purchase 820,597 newly issued shares of the Issuer's common stock for a purchase price of $0.9749 per share. On December 10, 2024, Mr. Chan directly entered into a stock purchase agreement with the Issuer, pursuant to which he agreed to purchase 205,149 newly issued shares of the Issuer's common stock for a purchase price of $0.9749 per share. Joint Filing Agreement between Heng Fai Chan, Global Biomedical Pte. Ltd. and Alset Inc., incorporated by reference to Amendment No. 13 to the Schedule 13D filed on September 20, 2021. Heng Fai Ambrose Chan /s/ Heng Fai Ambrose Chan 02/10/2025 Alset Inc. /s/ Heng Fai Ambrose Chan 02/10/2025 Global Biomedical Pte. Ltd. /s/ Heng Fai Ambrose Chan 02/10/2025 Alset International Limited /s/ Heng Fai Ambrose Chan 02/10/2025